Inhaled insulin: overview of a novel route of insulin administration
- PMID: 20234779
- PMCID: PMC2835554
- DOI: 10.2147/vhrm.s6098
Inhaled insulin: overview of a novel route of insulin administration
Abstract
Diabetes is a chronic disease characterized by inadequate insulin secretion with resulting hyperglycemia. Diabetes complications include both microvascular and macrovascular disease, both of which are affected by optimal diabetes control. Many individuals with diabetes rely on subcutaneous insulin administration by injection or continuous infusion to control glucose levels. Novel routes of insulin administration are an area of interest in the diabetes field, given that insulin injection therapy is burdensome for many patients. This review will discuss pulmonary delivery of insulin via inhalation. The safety of inhaled insulin as well as the efficacy in comparison to subcutaneous insulin in the various populations with diabetes are covered. In addition, the experience and pitfalls that face the development and marketing of inhaled insulin are discussed.
Keywords: glycemic control; hemoglobin A1c; inhalation; insulin; type 1 diabetes; type 2 diabetes.
Similar articles
-
Clinical evaluation of inhaled insulin.Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):1061-75. doi: 10.1016/j.addr.2006.07.019. Epub 2006 Aug 17. Adv Drug Deliv Rev. 2006. PMID: 17070613 Review.
-
Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.Ann Intern Med. 2006 Nov 7;145(9):665-75. doi: 10.7326/0003-4819-145-9-200611070-00009. Ann Intern Med. 2006. PMID: 17088580
-
Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS).Expert Opin Investig Drugs. 2007 Oct;16(10):1673-81. doi: 10.1517/13543784.16.10.1673. Expert Opin Investig Drugs. 2007. PMID: 17922630 Review.
-
Inhaled human insulin.Drugs Today (Barc). 2006 Apr;42(4):207-21. doi: 10.1358/dot.2006.42.4.977449. Drugs Today (Barc). 2006. PMID: 16703118 Review.
-
Inhaled insulin: a novel and non-invasive way for insulin administration?Curr Drug Saf. 2006 May;1(2):151-8. doi: 10.2174/157488606776930526. Curr Drug Saf. 2006. PMID: 18690926
Cited by
-
An in silico scientific basis for LL-37 as a therapeutic for Covid-19.Proteins. 2022 May;90(5):1029-1043. doi: 10.1002/prot.26198. Epub 2021 Aug 9. Proteins. 2022. PMID: 34333809 Free PMC article.
-
Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.Endocr Connect. 2018 Jan;7(1):R47-R55. doi: 10.1530/EC-17-0309. Epub 2017 Dec 12. Endocr Connect. 2018. PMID: 29233817 Free PMC article. Review.
-
Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin.AAPS PharmSciTech. 2011 Sep;12(3):958-64. doi: 10.1208/s12249-011-9647-5. Epub 2011 Jul 15. AAPS PharmSciTech. 2011. PMID: 21761276 Free PMC article.
-
New technologies for diabetes: a review of the present and the future.Int J Pediatr Endocrinol. 2012 Oct 26;2012(1):28. doi: 10.1186/1687-9856-2012-28. Int J Pediatr Endocrinol. 2012. PMID: 23098076 Free PMC article.
-
Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery.Drug Des Devel Ther. 2015 Jun 17;9:3109-18. doi: 10.2147/DDDT.S79322. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26124635 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention . Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2008. National diabetes fact sheet: general information and national estimates on diabetes in the United States. 2007. URL. http://www.cdc.gov/diabetes/pubs/factsheet07.htm. Accessed August 26, 2009.
-
- Bakker W, Eringa EC, Sipkema P, vanHinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009;335(1):165–189. - PubMed
-
- Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434–444. - PubMed
-
- Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol. 1987;59(8):750–755. - PubMed
-
- Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003;46(6):760–765. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical